US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist

0.649
-0.021-3.13%

Trading Jul 29 13:49 ET

31.57MMarket Cap-606P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

9.68%-9.78M

4.41%-39.96M

-4.22%-10.96M

-13.51%-7.8M

19.28%-10.37M

6.39%-10.83M

-7.64%-41.81M

1.23%-10.51M

-3.68%-6.87M

-31.50%-12.85M

Net income from continuing operations

5.81%-12.35M

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-20.04%-53.01M

-74.04%-14.59M

15.69%-10.96M

-28.49%-13.21M

Operating gains losses

----

3,825.00%157K

-38.37%159K

--0

---2K

118.56%4K

47,009.09%258K

--0

----

Depreciation and amortization

-3.52%849K

90.25%3.44M

46.72%851K

58.81%856K

85.37%849K

284.28%880K

201.58%1.81M

109.46%580K

-63.31%539K

-82.15%458K

Other non cash items

0.00%42K

221.90%167K

117.52%41K

2.38%43K

-21.15%41K

1,300.00%42K

---137K

---234K

--42K

--52K

Change In working capital

44.42%-274K

-362.36%-934K

-140.90%-647K

-84.03%246K

98.19%-40K

12.12%-493K

108.11%356K

76.65%1.58M

-6.55%1.54M

41.57%-2.21M

-Change in receivables

314.39%298K

-153.19%-1.64M

-105.15%-38K

-776.67%-526K

-596.30%-938K

-106.27%-139K

278.84%3.09M

131.13%738K

-105.30%-60K

138.49%189K

-Change in prepaid assets

27.63%-998K

106.93%25K

-76.14%210K

-32.30%746K

134.38%448K

-32.60%-1.38M

-81.45%-361K

23.07%880K

-42.60%1.1M

-4.91%-1.3M

-Change in payables and accrued expense

215.52%1.49M

237.45%1.36M

-89.74%31K

48.55%1.18M

260.16%1.44M

-8.41%-1.29M

-141.99%-988K

-59.79%302K

-45.70%795K

-220.11%-896K

-Change in other current liabilities

-13.65%-741K

-279.32%-2.79M

-114.20%-724K

-139.06%-710K

-260.00%-702K

-786.32%-652K

-125.29%-735K

-105.27%-338K

76.07%-297K

83.75%-195K

-Change in other working capital

-110.86%-322K

427.44%2.11M

---126K

---445K

---283K

559.84%2.97M

91.91%-645K

--0

Cash from discontinued investing activities

Operating cash flow

9.68%-9.78M

4.41%-39.96M

-4.22%-10.96M

-13.51%-7.8M

19.28%-10.37M

6.39%-10.83M

-7.64%-41.81M

1.23%-10.51M

-3.68%-6.87M

-31.50%-12.85M

Investing cash flow

Cash flow from continuing investing activities

-100.37%-55K

201.59%25M

116.94%5M

8,164.52%5M

55,662.96%15M

-370.19%-24.61M

978,177.89%5M

-268,263.64%-29.52M

73.39%-62K

Net PPE purchase and sale

-2,850.00%-55K

101.21%2K

--0

107.41%2K

81.49%-165K

-295.69%-1K

-581.82%-75K

73.39%-62K

Net investment purchase and sale

--0

202.27%25M

--0

116.98%5M

--5M

--15M

-344.45%-24.45M

--5M

---29.45M

--0

Cash from discontinued investing activities

Investing cash flow

-100.37%-55K

201.59%25M

--0

116.94%5M

8,164.52%5M

55,662.96%15M

-370.19%-24.61M

978,177.89%5M

-268,263.64%-29.52M

73.39%-62K

Financing cash flow

Cash flow from continuing financing activities

506.70%2.35M

-77.90%11.86M

-82.55%4.78M

51,088.89%4.59M

-81.09%2.1M

-97.44%388K

178.99%53.66M

271.20%27.4M

-102.56%-9K

4.15%11.11M

Net issuance payments of debt

---1M

-120.00%-2M

---1M

--0

--10M

--0

Net common stock issuance

--3.35M

-65.94%13.39M

-74.53%5.78M

--5.59M

-81.85%2.02M

--0

126.06%39.3M

223.04%22.7M

--0

7.26%11.11M

Proceeds from stock option exercised by employees

--0

-89.94%473K

--0

--85K

--388K

80.85%4.7M

773.96%4.7M

--0

Net other financing activities

----

54.54%-341K

100.55%1K

98.13%-9K

--0

Cash from discontinued financing activities

Financing cash flow

506.70%2.35M

-77.90%11.86M

-82.55%4.78M

51,088.89%4.59M

-81.09%2.1M

-97.44%388K

178.99%53.66M

271.20%27.4M

-102.56%-9K

4.15%11.11M

Net cash flow

Beginning cash position

-5.99%48.67M

-19.77%51.76M

83.56%54.84M

-19.95%53.05M

-17.27%56.32M

-19.77%51.76M

-13.99%64.52M

-55.92%29.88M

-10.52%66.28M

-7.26%68.08M

Current changes in cash

-264.25%-7.49M

75.71%-3.1M

-128.22%-6.18M

104.92%1.79M

-81.57%-3.27M

28.15%4.56M

-21.55%-12.76M

770.93%21.89M

-478.97%-36.4M

-371.64%-1.8M

End cash Position

-26.88%41.18M

-5.99%48.67M

83.56%54.84M

-19.95%53.05M

-17.27%56.32M

-19.77%51.76M

-55.92%29.88M

-10.52%66.28M

Free cash flow

9.18%-9.84M

4.80%-39.96M

-4.21%-10.96M

-12.23%-7.8M

19.69%-10.37M

6.61%-10.83M

-5.60%-41.98M

1.22%-10.52M

-4.65%-6.95M

-28.85%-12.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	9.68%-9.78M	4.41%-39.96M	-4.22%-10.96M	-13.51%-7.8M	19.28%-10.37M	6.39%-10.83M	-7.64%-41.81M	1.23%-10.51M	-3.68%-6.87M	-31.50%-12.85M
Net income from continuing operations	5.81%-12.35M	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-20.04%-53.01M	-74.04%-14.59M	15.69%-10.96M	-28.49%-13.21M
Operating gains losses	----	3,825.00%157K	-38.37%159K	--0	--0	---2K	118.56%4K	47,009.09%258K	--0	----
Depreciation and amortization	-3.52%849K	90.25%3.44M	46.72%851K	58.81%856K	85.37%849K	284.28%880K	201.58%1.81M	109.46%580K	-63.31%539K	-82.15%458K
Other non cash items	0.00%42K	221.90%167K	117.52%41K	2.38%43K	-21.15%41K	1,300.00%42K	---137K	---234K	--42K	--52K
Change In working capital	44.42%-274K	-362.36%-934K	-140.90%-647K	-84.03%246K	98.19%-40K	12.12%-493K	108.11%356K	76.65%1.58M	-6.55%1.54M	41.57%-2.21M
-Change in receivables	314.39%298K	-153.19%-1.64M	-105.15%-38K	-776.67%-526K	-596.30%-938K	-106.27%-139K	278.84%3.09M	131.13%738K	-105.30%-60K	138.49%189K
-Change in prepaid assets	27.63%-998K	106.93%25K	-76.14%210K	-32.30%746K	134.38%448K	-32.60%-1.38M	-81.45%-361K	23.07%880K	-42.60%1.1M	-4.91%-1.3M
-Change in payables and accrued expense	215.52%1.49M	237.45%1.36M	-89.74%31K	48.55%1.18M	260.16%1.44M	-8.41%-1.29M	-141.99%-988K	-59.79%302K	-45.70%795K	-220.11%-896K
-Change in other current liabilities	-13.65%-741K	-279.32%-2.79M	-114.20%-724K	-139.06%-710K	-260.00%-702K	-786.32%-652K	-125.29%-735K	-105.27%-338K	76.07%-297K	83.75%-195K
-Change in other working capital	-110.86%-322K	427.44%2.11M	---126K	---445K	---283K	559.84%2.97M	91.91%-645K	--0	--0	--0
Cash from discontinued investing activities
Operating cash flow	9.68%-9.78M	4.41%-39.96M	-4.22%-10.96M	-13.51%-7.8M	19.28%-10.37M	6.39%-10.83M	-7.64%-41.81M	1.23%-10.51M	-3.68%-6.87M	-31.50%-12.85M
Investing cash flow
Cash flow from continuing investing activities	-100.37%-55K	201.59%25M	0	116.94%5M	8,164.52%5M	55,662.96%15M	-370.19%-24.61M	978,177.89%5M	-268,263.64%-29.52M	73.39%-62K
Net PPE purchase and sale	-2,850.00%-55K	101.21%2K	--0	--0	--0	107.41%2K	81.49%-165K	-295.69%-1K	-581.82%-75K	73.39%-62K
Net investment purchase and sale	--0	202.27%25M	--0	116.98%5M	--5M	--15M	-344.45%-24.45M	--5M	---29.45M	--0
Cash from discontinued investing activities
Investing cash flow	-100.37%-55K	201.59%25M	--0	116.94%5M	8,164.52%5M	55,662.96%15M	-370.19%-24.61M	978,177.89%5M	-268,263.64%-29.52M	73.39%-62K
Financing cash flow
Cash flow from continuing financing activities	506.70%2.35M	-77.90%11.86M	-82.55%4.78M	51,088.89%4.59M	-81.09%2.1M	-97.44%388K	178.99%53.66M	271.20%27.4M	-102.56%-9K	4.15%11.11M
Net issuance payments of debt	---1M	-120.00%-2M	---1M	---1M	--0	--0	--10M	--0	--0	--0
Net common stock issuance	--3.35M	-65.94%13.39M	-74.53%5.78M	--5.59M	-81.85%2.02M	--0	126.06%39.3M	223.04%22.7M	--0	7.26%11.11M
Proceeds from stock option exercised by employees	--0	-89.94%473K	--0	--0	--85K	--388K	80.85%4.7M	773.96%4.7M	--0	--0
Net other financing activities	----	----	----	----	----	----	54.54%-341K	100.55%1K	98.13%-9K	--0
Cash from discontinued financing activities
Financing cash flow	506.70%2.35M	-77.90%11.86M	-82.55%4.78M	51,088.89%4.59M	-81.09%2.1M	-97.44%388K	178.99%53.66M	271.20%27.4M	-102.56%-9K	4.15%11.11M
Net cash flow
Beginning cash position	-5.99%48.67M	-19.77%51.76M	83.56%54.84M	-19.95%53.05M	-17.27%56.32M	-19.77%51.76M	-13.99%64.52M	-55.92%29.88M	-10.52%66.28M	-7.26%68.08M
Current changes in cash	-264.25%-7.49M	75.71%-3.1M	-128.22%-6.18M	104.92%1.79M	-81.57%-3.27M	28.15%4.56M	-21.55%-12.76M	770.93%21.89M	-478.97%-36.4M	-371.64%-1.8M
End cash Position	-26.88%41.18M	-5.99%48.67M	-5.99%48.67M	83.56%54.84M	-19.95%53.05M	-17.27%56.32M	-19.77%51.76M	-19.77%51.76M	-55.92%29.88M	-10.52%66.28M
Free cash flow	9.18%-9.84M	4.80%-39.96M	-4.21%-10.96M	-12.23%-7.8M	19.69%-10.37M	6.61%-10.83M	-5.60%-41.98M	1.22%-10.52M	-4.65%-6.95M	-28.85%-12.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall